Sofia Genta

1.2k total citations · 1 hit paper
36 papers, 742 citations indexed

About

Sofia Genta is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sofia Genta has authored 36 papers receiving a total of 742 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 12 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sofia Genta's work include Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (8 papers) and Ovarian cancer diagnosis and treatment (5 papers). Sofia Genta is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Cancer Genomics and Diagnostics (8 papers) and Ovarian cancer diagnosis and treatment (5 papers). Sofia Genta collaborates with scholars based in Canada, Italy and United States. Sofia Genta's co-authors include Giorgio Valabrega, Eleonora Ghisoni, Gaia Giannone, Gloria Mittica, Massimo Aglietta, Lillian L. Siu, Jesús Fuentes‐Antrás, Abi Vijenthira, Giulia Scotto and Valentina Tuninetti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Sofia Genta

34 papers receiving 731 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antibody–drug conjugates: in search of partners of choice

2023 128 citations Jesús Fuentes‐Antrás, Sofia Genta et al. Trends in cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sofia Genta Canada	12	434	289	170	139	135	36	742
Sophia Frentzas Australia	14	388 0.9×	276 1.0×	121 0.7×	152 1.1×	112 0.8×	65	737
Elena Poddubskaya Russia	16	478 1.1×	312 1.1×	129 0.8×	269 1.9×	236 1.7×	57	846
Andrea Milani Italy	12	416 1.0×	268 0.9×	109 0.6×	208 1.5×	123 0.9×	35	765
Natalie Y.L. Ngoi Singapore	17	506 1.2×	428 1.5×	131 0.8×	121 0.9×	146 1.1×	70	919
Emma Kipps United Kingdom	8	292 0.7×	268 0.9×	125 0.7×	94 0.7×	157 1.2×	26	693
Matin Sheriff United Kingdom	16	551 1.3×	364 1.3×	117 0.7×	193 1.4×	170 1.3×	33	1.0k
Stéphanie Lheureux Canada	15	735 1.7×	331 1.1×	161 0.9×	116 0.8×	135 1.0×	46	991
Evelien W. Duiker Netherlands	14	345 0.8×	332 1.1×	291 1.7×	48 0.3×	114 0.8×	26	750
Liancheng Zhu China	20	226 0.5×	657 2.3×	238 1.4×	172 1.2×	307 2.3×	72	1.1k
Evangelos Bournakis Greece	15	267 0.6×	272 0.9×	39 0.2×	160 1.2×	153 1.1×	35	621

Countries citing papers authored by Sofia Genta

Since Specialization

Citations

This map shows the geographic impact of Sofia Genta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofia Genta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofia Genta more than expected).

Fields of papers citing papers by Sofia Genta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofia Genta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofia Genta. The network helps show where Sofia Genta may publish in the future.

Co-authorship network of co-authors of Sofia Genta

This figure shows the co-authorship network connecting the top 25 collaborators of Sofia Genta. A scholar is included among the top collaborators of Sofia Genta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofia Genta. Sofia Genta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Siu, Lillian L., Timothy A. Yap, Sofia Genta, et al.. (2025). A First-in-Human Study of ATM Inhibitor Lartesertib as Monotherapy in Patients with Advanced Solid Tumors. Clinical Cancer Research. 31(21). 4429–4437. 1 indexed citations

Spiliopoulou, Pavlina, Stephen B. Strum, Alexandra Easson, et al.. (2024). 226TiP CLEAR-Me: Interception trial to detect and clear molecular residual disease in patients with high-risk melanoma. Annals of Oncology. 35. S306–S306. 1 indexed citations

Spiliopoulou, Pavlina, Olga Vornicova, Sofia Genta, & Anna Spreafico. (2023). Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. International Journal of Molecular Sciences. 24(2). 1294–1294. 8 indexed citations

Ribeiro, Maria Flávia Marques, Elizabeth Koch, Sofia Genta, et al.. (2023). 1131P Management of metastatic uveal melanoma (MUM) patients on tebentafusp in a real-world setting. Annals of Oncology. 34. S679–S679. 3 indexed citations

Fuentes‐Antrás, Jesús, Sofia Genta, Abi Vijenthira, & Lillian L. Siu. (2023). Antibody–drug conjugates: in search of partners of choice. Trends in cancer. 9(4). 339–354. 128 indexed citations breakdown →

Vanner, Robert J., Andy G.X. Zeng, Michelle Chan‐Seng‐Yue, et al.. (2023). Somatic TET2 Mutations Prime the Immune System for Response to Immune Checkpoint Blockade. Blood. 142(Supplement 1). 2689–2689. 1 indexed citations

Spiliopoulou, Pavlina, Sofia Genta, Ben X. Wang, et al.. (2023). Intestinal microbiome characterization in immune checkpoint inhibition (ICI) resistant disease.. Journal of Clinical Oncology. 41(16_suppl). 2515–2515. 1 indexed citations

Genta, Sofia, Bryan Coburn, David W. Cescon, & Anna Spreafico. (2022). Patient-derived cancer models: Valuable platforms for anticancer drug testing. Frontiers in Oncology. 12. 976065–976065. 22 indexed citations

Colombo, Ilaria, Sofia Genta, Federica Martorana, et al.. (2021). Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors. Clinical Cancer Research. 27(18). 5012–5019. 27 indexed citations

10.

Rose, April A. N., Sofia Genta, Deirdre Kelly, et al.. (2021). 531P Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations (mts): Preliminary results of the investigator initiated phase II BEAVER trial. Annals of Oncology. 32. S596–S596.

11.

Genta, Sofia, Federica Martorana, Anastasios Stathis, & Ilaria Colombo. (2021). Targeting the DNA damage response: PARP inhibitors and new perspectives in the landscape of cancer treatment. Critical Reviews in Oncology/Hematology. 168. 103539–103539. 16 indexed citations

12.

Artioli, Grazia, Gaia Giannone, Giorgio Valabrega, et al.. (2021). Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21). Gynecologic Oncology. 161(3). 755–761. 8 indexed citations

13.

Govindan, Ramaswamy, Amanda Townsend, Kathy D. Miller, et al.. (2021). Trial in progress: A phase 1, multicenter, open-label, dose-exploration and dose-expansion study evaluating the safety, tolerability, pharmacokinetics, and efficacy of AMG650 in subjects with advanced solid tumors.. Journal of Clinical Oncology. 39(15_suppl). TPS5600–TPS5600. 3 indexed citations

14.

Colombo, Ilaria, Sofia Genta, Federica Martorana, et al.. (2020). 568P Phase I dose-escalation study of the dual PI3K/mTORC1/2 inhibitor Gedatolisib (PF-05212384) in combination with paclitaxel (P) and carboplatin (C) in patients (pts) with advanced solid tumours. Annals of Oncology. 31. S487–S487. 3 indexed citations

15.

Erriquez, Jessica, Giulia Mesiano, Sofia Genta, et al.. (2020). Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer. Scientific Reports. 10(1). 6478–6478. 10 indexed citations

16.

Ghisoni, Eleonora, Furio Maggiorotto, Fulvio Borella, et al.. (2019). TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers. Journal of Ovarian Research. 12(1). 17–17. 23 indexed citations

17.

Genta, Sofia, Maria Cristina Pirosa, & Anastasios Stathis. (2019). BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer. Current Oncology Reports. 21(2). 13–13. 24 indexed citations

18.

Giannone, Gaia, Andrea Milani, Eleonora Ghisoni, et al.. (2018). Oral etoposide in heavily pre-treated metastatic breast cancer: A retrospective series. The Breast. 38. 160–164. 17 indexed citations

19.

Mittica, Gloria, Rebecca Senetta, Giulia Scotto, et al.. (2017). Androgen receptor status predicts development of brain metastases in ovarian cancers. Oncotarget. 8(25). 41143–41153. 13 indexed citations

20.

Martinello, Rossella, Sofia Genta, Danilo Galizia, et al.. (2016). New and developing chemical pharmacotherapy for treating hormone receptor-positive/HER2-negative breast cancer. Expert Opinion on Pharmacotherapy. 17(16). 2179–2189. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact